Skip to content

CDR

CVS kicks off gift card-with-purchase promo

CVS/pharmacy has launched a promotion in which loyalty card customers earn free gift cards by purchasing designated items. The drug store chain said Monday that under the promotion, which began Oct. 16 and runs to Dec.

With retirements, Eli Lilly promotes senior staff

Eli Lilly and Co. is promoting a trio of senior executives with the announcement that longtime company Bryce Carmine and Frank Deane plan to retire. The pharmaceutical company said this week that Carmine and Deane are slated to retire as of Dec. 31.

Rite Aid recognized for wellness+ rewards program

Rite Aid Corp.’s wellness+ customer rewards program has received its own reward: the Shopper Technology Institute’s 2011 LEADER Award. Rite Aid said Friday that it won the award, sponsored by IBM, in the loyalty category.

Beiersdorf sets CEO succession plan

Next spring, Beiersdorf AG will have a new chief executive officer at the helm. The supervisory board of the skin care and cosmetics manufacturer has named Stefan Heidenreich as the company’s next chief executive officer. Plans call for Heidenreich to take the reins as CEO on April 26, 2012.

Game-changer is emerging in community Rx

Game-changer is emerging in community Rx

It is almost six years since the beginning of Medicare Part D. But now, the development of a system to use quality-based payments for quality-based patient outcomes is coming closer to ­reality. Imagine a Medicare Advantage Plan that includes drug benefits (MAPD) with 1 million members.

NCPA: Community pharmacies rein in health care costs

Amid a difficult economic environment, independent community pharmacies are growing their array of services to better meet patients’ needs and lower their health care costs, according to the National Community Pharmacists Association’s 2011 NCPA Digest.

Staff realigned at Walgreens

Walgreen Co. has restructured its marketing and merchandising staff in a bid to foster a more integrated approach to the two disciplines and intensify the drug chain’s customer focus. A major component of the realignment was the elimination of the chief marketing officer’s role.